Prevention of Prostate Cancer with Finasteride: US/European Perspective
- 1 December 2003
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 44 (6) , 650-655
- https://doi.org/10.1016/j.eururo.2003.11.001
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screeningUrology, 2003
- Prognostic Significance of Tumor Volume after Radical Prostatectomy: A Multivariate Analysis of Pathological Prognostic FactorsEuropean Urology, 2003
- Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice StudyJournal of Urology, 2003
- Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor featuresUrology, 2002
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European prostate cancer detection studyThe Prostate, 2001
- Preoperative Serum Prostate-specific Antigen (PSA) Below 10 μg/L Predicts Neither the Presence of Prostate Cancer Nor the Rate of Postoperative PSA FailureClinical Chemistry, 2001
- Gleason Scores from Prostate Biopsies Obtained with 18-Gauge Biopsy Needles Poorly Predict Gleason Scores of Radical Prostatectomy SpecimensEuropean Urology, 1998
- Workgroup 5: Assessment of prostate carcinoma in core needle biopsy--Definition of minimal criteria for the diagnosis of cancer in biopsy materialCancer, 1996